These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9449654)

  • 1. A proliferative effect of transforming growth factor-beta1 on a human prostate cancer cell line, TSU-Pr1.
    Lamm ML; Sintich SM; Lee C
    Endocrinology; 1998 Feb; 139(2):787-90. PubMed ID: 9449654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
    Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
    Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate.
    Djakiew D; Delsite R; Pflug B; Wrathall J; Lynch JH; Onoda M
    Cancer Res; 1991 Jun; 51(12):3304-10. PubMed ID: 1710170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of TSU-Pr1, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone.
    Enomoto M; Seong JY; Kawashima S; Park MK
    Life Sci; 2004 May; 74(25):3141-52. PubMed ID: 15081579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1-induced proliferation of the prostate cancer cell line, TSU-Pr1: the role of platelet-derived growth factor.
    Sintich SM; Lamm ML; Sensibar JA; Lee C
    Endocrinology; 1999 Aug; 140(8):3411-5. PubMed ID: 10433194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
    Park BJ; Park JI; Byun DS; Park JH; Chi SG
    Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone.
    Rajan R; Vanderslice R; Kapur S; Lynch J; Thompson R; Djakiew D
    Prostate; 1996 Jan; 28(1):1-9. PubMed ID: 8545275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
    Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
    Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
    Zolfaghari A; Djakiew D
    Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.
    Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C
    Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S; Dong Z
    Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
    Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
    Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal-epithelial paracrine interactions in the neoplastic rat and human prostate.
    Djakiew D; Pflug B; Onoda M
    Adv Exp Med Biol; 1993; 330():185-202. PubMed ID: 8368133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY; Zelner DJ; Lee C
    Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose staurosporine suppresses proliferation and induces neurites in human prostatic cancer TSU-Pr1 cells.
    Takahashi N; Shimizu T; Takeda K
    Prostate; 2000 Sep; 44(4):328-33. PubMed ID: 10951498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.